Huadong Medicine Stock Forum

Despite Huadong Medicine's strong earnings outlook and rapid growth, its low P/E ratio suggests investor skepticism about future earnings volatility. The company also shows 1 warning sign in investment analysis.

Despite the short-term decrease in returns on capital, the growth in revenue and capital employed for Huadong Medicine is seen as promising. If these growth trends continue, the stock could perform well in the future.

Despite falling EPS, rising share price hint at the market valuing future potential. Positive sentiments may be due to steady revenue growth, indicating investor anticipation. Dividend payments over last 3 years contributed significantly with a 68% total shareholder return.

Core point
1. In the past three years, China's medical beauty industry has undergone earth-shaking changes, and non-surgical products occupy the mainstream
2. The brand is a marketing tool and a social contract for the legal entity to face society. Last year, it began to issue documents on supervising medical aesthetics, focusing on doctors' qualifications, marketing, and the capabilities of three types of ...